Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Ethacrynic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSTP1 | P09211 | 14/20 | 1.00 |
| ▸ | GSTA1 | P08263 | 8/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 2/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 1.00 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 1.00 |
| ▸ | MEN1 | O00255 | 1/20 | 1.00 |
| ▸ | ABCC3 | O15438 | 1/20 | 1.00 |
| ▸ | PLIN1 | O60240 | 1/20 | 1.00 |
| ▸ | LMNA | P02545 | 1/20 | 1.00 |
| ▸ | TP53 | P04637 | 1/20 | 1.00 |
| ▸ | MAPT | P10636 | 1/20 | 1.00 |
| ▸ | HSPD1 | P10809 | 1/20 | 1.00 |
| ▸ | TSHR | P16473 | 1/20 | 1.00 |
| ▸ | HTT | P42858 | 1/20 | 1.00 |
| ▸ | RECQL | P46063 | 1/20 | 1.00 |
| ▸ | MAP2K6 | P52564 | 1/20 | 1.00 |
| ▸ | HSPE1 | P61604 | 1/20 | 1.00 |
| ▸ | GSTO1 | P78417 | 1/20 | 1.00 |
| ▸ | PLIN5 | Q00G26 | 1/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethacrynic Acid SCHEMBL29384243 | 1.00 | GSTP1 (1.00) | GSTP1GSTA1CYP2C9ALDH1A1NPSR1 | |
| Ethacrynic Acid SCHEMBL9108011 | 1.00 | GSTP1 (1.00) | GSTP1GSTA1CYP2C9ALDH1A1NPSR1 | |
| Ethacrynic Acid SCHEMBL2482896 | 0.99 | GSTP1 (0.97) | GSTP1GSTA1CYP2C9ALDH1A1NPSR1 | |
| Ethacrynic Acid SCHEMBL905726 | 0.99 | GSTP1 (0.97) | GSTP1GSTA1CYP2C9ALDH1A1NPSR1 | |
| Ethacrynic Acid SCHEMBL3713733 | 0.99 | GSTP1 (0.97) | GSTP1GSTA1CYP2C9ALDH1A1NPSR1 | |
| Ethacrynic Acid SCHEMBL18263238 | 0.93 | GSTP1 (0.86) | GSTP1GSTA1CYP2C9ALDH1A1NPSR1 | |
| Ethacrynic Acid SCHEMBL8907134 | 0.92 | GSTP1 (0.84) | GSTP1GSTA1CYP2C9ALDH1A1NPSR1 | |
| SCHEMBL10001217 | 0.89 | GSTP1 (0.81) | GSTP1GSTA1CYP2C9ALDH1A1NPSR1 | |
| SCHEMBL10543330 | 0.89 | GSTP1 (0.81) | GSTP1GSTA1CYP2C9ALDH1A1NPSR1 | |
| SCHEMBL9717560 | 0.89 | GSTP1 (0.80) | GSTP1GSTA1CYP2C9ALDH1A1NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 21563 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026085577-A1 | INSECTICIDE COMPOSITION AND USE THEREOF | CALLINGTON HAVEN PTY LTD (AU) | 2026-04-30 | — | — | WO | claimed |
| WO-2026085578-A1 | RESIDUAL INSECTICIDE COMPOSITION AND USE THEREOF | CALLINGTON HAVEN PTY LTD (AU) | 2026-04-30 | — | — | WO | claimed |
| EP-4722714-A1 | SIMULTANEOUS ANALYSIS OF FOOD-BORNE DOPING SUBSTANCES USING LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY (VFD: VACCINE FOR FOODBORNE DOPING) | Korea Institute of Science and Technology (KR) | 2026-04-08 | — | — | EP | claimed |
| EP-4713094-A2 | PHARMACEUTICAL COMPOSITION AND METHOD FOR PREVENTION AND TREATMENT OF HEARING LOSS | Pharmazz, Inc. (US) | 2026-03-25 | — | — | EP | claimed |
| EP-4710928-A2 | METHODS OF TREATING IGA NEPHROPATHY WITH ATRASENTAN | Chinook Therapeutics, Inc. (US) | 2026-03-18 | — | — | EP | claimed |
| EP-4426368-B1 | APPARATUS FOR EXTRACORPOREAL BLOOD TREATMENT | GAMBRO LUNDIA AB (SE) | 2025-11-26 | — | — | EP | claimed |
| US-20250352511-A1 | METHODS OF TREATING FOCAL SEGMENTAL GLOMERULOSCLEROSIS WITH ATRASENTAN | CHINOOK THERAPEUTICS INC (US) | 2025-11-20 | — | — | US | claimed |
| US-20250345332-A1 | APROCITENTAN FOR THE TREATMENT OF HYPERTENSION | IDORSIA PHARMACEUTICALS LTD (CH) | 2025-11-13 | — | — | US | claimed |
| US-20250345461-A1 | METHOD FOR REPAIRING HAIR CYCLE-RELATED GENES AND METHOD FOR TREATING HAIR CYCLE-RELATED DISEASES USING MIR-520D-5P | LIVIUS PTE LTD (SG) | 2025-11-13 | — | — | US | claimed |
| EP-4642536-A2 | COMPOSITION AND METHOD FOR WOUND HEALING AND REPAIR OF DAMAGED NERVES | Pharmazz, Inc. (US) | 2025-11-05 | — | — | EP | claimed |
| EP-0051964-A2 | Animal growth control | Naylor, Graham John (GB) | 1982-05-19 | — | — | EP | claimed |
| US-4311697-A | HYPOTENSIVE AGENTS | E. R. SQUIBB & SONS, INC. (US) | 1982-01-19 | — | — | US | claimed |
| US-4285947-A | DIURETICS, HYPOTENSIVES | INTERX RESEARCH CORPORATION (US) | 1981-08-25 | — | — | US | claimed |
| EP-0032725-A1 | Novel aldehyde adducts of triamterene and a pharmaceutical composition containing the same | MERCK & CO. INC. (US) | 1981-07-29 | — | — | EP | claimed |
| US-4265893-A | 2,4-DIAMINO-5-(4-AMINO-3,5-DIALKOXY BENZYL) PYRIMIDINE AS POTASSIUM RETAINING COMPOUND | HOFFMANN-LA ROCHE INC. (US) | 1981-05-05 | — | — | US | claimed |
| US-4261985-A | REDUCED EXCRETION OF POTASSIUM IONS BY INCLUSION OF ALDOSTERONE ANTAGONIST | CIBA-GEIGY CORPORATION (US) | 1981-04-14 | — | — | US | claimed |
| US-4217347-A | MERCAPTOALKYL ALKANOYLPROLINES AND A DIURETIC | E. R. SQUIBB & SONS, INC. (US) | 1980-08-12 | — | — | US | claimed |
| EP-0012401-A1 | Carboxyalkyl dipeptide derivatives, process for preparing them and pharmaceutical composition containing them | MERCK & CO. INC. (US) | 1980-06-25 | — | — | EP | claimed |
| EP-0005057-A1 | A material and composition for reducing blood pressure | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1979-10-31 | — | — | EP | claimed |
| US-4110445-A | METHOD FOR ANTAGONIZING ALDOSTERONIC ACTION AND INDUCING DIURESIS BY ADMINISTERING A TETRASUBSTITUTED IMIDAZOLIDINE | AMERICAN CYANAMID COMPANY (US) | 1978-08-29 | — | — | US | claimed |